Scottish biotechnology company Roslin Technologies has raised GBP 11 million (~USD 12 million) in a Series A funding round led by Novo Holdings.
The funding is expected to assist the company in its mission to become the leading supplier of cell media for cultivated meat production by allowing the company to expand its cell-line portfolio and further development of protocols aimed at scaling up its cells into cost-effective cell biomass for meat production.
The new growth efforts are expected to be done in collaboration with the company’s customers, development partners, and the University of Edinburgh.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.